Company intelligence / Profile preview

MCI Bio-Peptide

Ownership: Private
Development stage: Other

Overview

MCI Bio-Peptide is an innovative pharmaceutical company specializing in the manufacturing of hormonal-based products and peptides. The company emphasizes GMP-certified production, detailed molecular-level research, global academic collaborations, and participation in clinical trials with volunteers. No published clinical results or late-stage trial data were found.

Therapeutic areas: EndocrinologyOncology
Modalities: PeptidesHormone
Industry: Biotech

Partnerships

No major pharmaceutical or biotech partnerships specifically named; the company highlights broad academic collaborations globally.

Beyond the preview

Go deeper on MCI Bio-Peptide.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MCI Bio-Peptide.

Explore the full profile